Cargando…

Cerebral Cavernous Malformation 1 Determines YAP/TAZ Signaling-Dependent Metastatic Hallmarks of Prostate Cancer Cells

SIMPLE SUMMARY: Our analysis of cerebral cavernous malformation 1 (CCM1) expression and function reveals a candidate predictive biomarker for prostate cancer metastasis and provides evidence that CCM1 abnormality can be pathogenic in prostate cancer. In particular, the CCM1 regulation of metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sangryong, Lee, Ho-Young, Kim, Jayoung, Park, Hansol, Ju, Young Seok, Kim, Eung-Gook, Kim, Jaehong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961486/ https://www.ncbi.nlm.nih.gov/pubmed/33807895 http://dx.doi.org/10.3390/cancers13051125

Ejemplares similares

Introduction to cerebral cavernous malformation: a brief review
por: Kim, Jaehong
Publicado: (2016)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Unusual Presentation of Cerebral Cavernous Malformation
por: Kim, Won-Hyung, et al.
Publicado: (2015)

YAP/TAZ initiate and maintain Schwann cell myelination
por: Grove, Matthew, et al.
Publicado: (2017)

DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)

The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness
por: Park, Hyunjin, et al.
Publicado: (2021)

Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
por: Faraji, Farhoud, et al.
Publicado: (2022)

YAP/TAZ Activation as a Target for Treating Metastatic Cancer
por: Warren, Janine S. A., et al.
Publicado: (2018)

The cerebral cavernous malformations proteins
por: Li, Xiaofeng, et al.
Publicado: (2015)

The Short-Chain Fatty Acid Receptor GPR43 Modulates YAP/TAZ via RhoA
por: Park, Bi-Oh, et al.
Publicado: (2021)

A Spinal Cavernous Malformation in Multiple Cerebral Cavernous Venous Malformations Syndrome
por: Vangrinsven, Guillaume, et al.
Publicado: (2023)

Pineal Cavernous Malformations: Report of Two Cases
por: Kim, Dong-Seok, et al.
Publicado: (2005)

Giant Cystic Cerebral Cavernous Malformation with Multiple Calcification - Case Report
por: Kim, Il-Chun, et al.
Publicado: (2013)

YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells
por: Bierbaumer, Lisa, et al.
Publicado: (2021)

Advances in the biology of cerebral cavernous malformations
por: Kivelev, Juri, et al.
Publicado: (2010)

Advances in the biology of cerebral cavernous malformations
por: Hauptman, Jason S., et al.
Publicado: (2010)

Postzygotic mosaicism in cerebral cavernous malformation
por: Rath, Matthias, et al.
Publicado: (2020)

YAP and TAZ regulate cell volume
por: Perez-Gonzalez, Nicolas A., et al.
Publicado: (2019)

Mechanisms of YAP/TAZ transcriptional control
por: Battilana, Giusy, et al.
Publicado: (2021)

YAP/TAZ in Bone and Cartilage Biology
por: Zarka, Mylène, et al.
Publicado: (2022)

YAP/TAZ dull the STING of aging
por: Francisco, Jamie, et al.
Publicado: (2022)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

AR activates YAP/TAZ differentially in prostate cancer
por: Salem, Omar, et al.
Publicado: (2023)

Microsurgical Treatment and Outcome of Pediatric Supratentorial Cerebral Cavernous Malformation
por: Noh, Jung-Hoon, et al.
Publicado: (2014)

Clinicoradiologic data of familial cerebral cavernous malformation with age‐related disease burden
por: Kim, Seondeuk, et al.
Publicado: (2023)

CCM3 and cerebral cavernous malformation disease
por: Wang, Kang, et al.
Publicado: (2019)

Recent advances in cerebral cavernous malformation research
por: Padarti, Akhil, et al.
Publicado: (2018)

Pregnancy Combined with Epilepsy and Cerebral Cavernous Malformation
por: Xu, Ya-Lan, et al.
Publicado: (2017)

Gamma Knife radiosurgery for cerebral cavernous malformation
por: Lee, Cheng-Chia, et al.
Publicado: (2019)

Cerebral Cavernous Malformations: The Importance of Cutaneous Manifestations
por: Vázquez-Osorio, Igor, et al.
Publicado: (2021)

Cervical Cord Hemorrhage in Cerebral Cavernous Malformations
por: Wang, Zhanjun, et al.
Publicado: (2021)

Tailored Treatment Options for Cerebral Cavernous Malformations
por: Hoffman, Jessa E., et al.
Publicado: (2022)

Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives
por: Tu, Tianqi, et al.
Publicado: (2022)

Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
por: Globisch, Maria Ascencion, et al.
Publicado: (2022)

Role of pericytes in the development of cerebral cavernous malformations
por: Dai, Zifeng, et al.
Publicado: (2022)

Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation
por: Globisch, Maria A., et al.
Publicado: (2022)

Varying clinical presentations of familial cerebral cavernous malformations (CCMs) and spinal cord cavernous malformations (SCCMs)
por: Nicholas-Bublick, Selena, et al.
Publicado: (2015)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)

YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells
por: Choi, Sung Yong, et al.
Publicado: (2020)

Context-dependent roles of YAP/TAZ in stem cell fates and cancer
por: LeBlanc, Lucy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s7spvd9vqbbgmsk3uoktqnvhch